Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Return on Assets (2021 - 2025)

Historic Return on Assets for Rhythm Pharmaceuticals (RYTM) over the last 6 years, with Q3 2025 value amounting to 0.44%.

  • Rhythm Pharmaceuticals' Return on Assets rose 2600.0% to 0.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.44%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.72% for FY2024, which is 2000.0% down from last year.
  • As of Q3 2025, Rhythm Pharmaceuticals' Return on Assets stood at 0.44%, which was up 2600.0% from 0.48% recorded in Q2 2025.
  • Rhythm Pharmaceuticals' 5-year Return on Assets high stood at 0.06% for Q2 2021, and its period low was 0.93% during Q1 2024.
  • Its 5-year average for Return on Assets is 0.49%, with a median of 0.54% in 2023.
  • Per our database at Business Quant, Rhythm Pharmaceuticals' Return on Assets plummeted by -6000bps in 2022 and then soared by 4900bps in 2025.
  • Rhythm Pharmaceuticals' Return on Assets (Quarter) stood at 0.23% in 2021, then tumbled by -107bps to 0.47% in 2022, then decreased by -15bps to 0.54% in 2023, then decreased by -28bps to 0.69% in 2024, then soared by 37bps to 0.44% in 2025.
  • Its last three reported values are 0.44% in Q3 2025, 0.48% for Q2 2025, and 0.43% during Q1 2025.